BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9396639)

  • 1. Rationale for low-molecular weight heparin in coronary stenting.
    Zidar JP
    Am Heart J; 1997 Nov; 134(5 Pt 2):S81-7. PubMed ID: 9396639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin in coronary stenting.
    Zidar JP
    Can J Cardiol; 1998 Aug; 14 Suppl E():35E-39E. PubMed ID: 9779032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy after intracoronary stenting.
    Spinler S; Cheng J
    Pharmacotherapy; 1997; 17(1):74-90. PubMed ID: 9017767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.
    Mehran R; Aymong ED; Ashby DT; Fischell T; Whitworth H; Siegel R; Thomas W; Wong SC; Narasimaiah R; Lansky AJ; Leon MB
    Circulation; 2003 Sep; 108(9):1078-83. PubMed ID: 12925457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    Schömig A; Neumann FJ; Kastrati A; Schühlen H; Blasini R; Hadamitzky M; Walter H; Zitzmann-Roth EM; Richardt G; Alt E; Schmitt C; Ulm K
    N Engl J Med; 1996 Apr; 334(17):1084-9. PubMed ID: 8598866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary artery stenting without antivitamin K. Results after a month].
    Zemour G; Morice MC; Benveniste E; Biron Y; Lienhart Y; Valeix B; Louvard Y; Glatt B; Lefevre T; Guérin Y
    Arch Mal Coeur Vaiss; 1996 Mar; 89(3):291-7. PubMed ID: 8734180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current roles and future possibilities for low-molecular-weight heparins in unstable angina.
    Purcell H; Fox KM
    Eur Heart J; 1998 Sep; 19 Suppl K():K18-23. PubMed ID: 9790285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The assessment of safety of enoxaparin administration during percutaneous transluminal coronary angioplasty after ticlopidine pretreatment. Application of low molecular weigh heparins in prevention of coronary micro-embolization].
    Dudek D; Zymek P; Bartuś S; Dubiel JS
    Przegl Lek; 2001; 58(6):484-6. PubMed ID: 11816736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticlopidine and aspirin therapy following implantation of coronary artery stents.
    Hobson AG; Sowinski KM
    Ann Pharmacother; 1997 Jun; 31(6):770-2. PubMed ID: 9184720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary antithrombotic strategies in patients undergoing coronary stent implantation.
    Bartorelli AL; Trabattoni D
    Minerva Cardioangiol; 2002 Oct; 50(5):517-30. PubMed ID: 12384634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study.
    Machraoui A; Germing A; Lindstaedt M; von Dryander S; Bojara W; Lawo T; Lemke B; Jaeger D; Grewe P; Deneke T; Barmeyer J
    J Invasive Cardiol; 2001 Jun; 13(6):431-6. PubMed ID: 11385163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [-Anticoagulation after intracoronary stent implantation-].
    Bode C; Nordt TK; Kübler W
    Herz; 1996 Feb; 21(1):60-3. PubMed ID: 8647580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
    May AE; Geisler T; Gawaz M
    Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
    Leon MB; Baim DS; Popma JJ; Gordon PC; Cutlip DE; Ho KK; Giambartolomei A; Diver DJ; Lasorda DM; Williams DO; Pocock SJ; Kuntz RE
    N Engl J Med; 1998 Dec; 339(23):1665-71. PubMed ID: 9834303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.